Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackfinch Spr. Regulatory News (BFSP)

Share Price Information for Blackfinch Spr. (BFSP)

Share Price is delayed by 15 minutes
Get Live Data
85.00    0.00 (0.00%)
Bid:
83.00
Ask:
87.00
Spread: 4.00 (4.819%)
Market Cap: £74.46m
BFSP Live PriceLast checked at - London Stock Exchange

Intraday Blackfinch Spr. Share Chart

Result of AGM

8 Jun 2022 11:48

RNS Number : 1707O
Blackfinch Spring VCT PLC
08 June 2022
 

Blackfinch Spring VCT plc (the "Company")

Results of Annual General Meeting (the "Meeting")

 

At the Annual General Meeting of the Company held on Wednesday 8 June 2022 at 10.00am, the following resolutions were duly passed.

 

Ordinary Resolutions

 

1. To receive and adopt the Directors' Report and Financial Statements of the Company for the financial year ended 31

December 2021 together with the Independent Auditor's Report thereon.

 

2. To approve the Directors' Remuneration Report for the year ended 31 December 2021 other than the part of such

Report containing the Directors' Remuneration Policy.

 

3. To appoint BDO LLP as the auditor of the Company from the conclusion of the Meeting until the conclusion of the

next annual general meeting of the Company to be held in 2023 at which financial statements are laid before the

Company.

 

4. To authorise the directors to fix the remuneration of the auditor.

 

5. To re-elect Kate Jones as a director of the Company in accordance with the Articles of

Association.

 

6. To re-elect Reuben Wilcock as a director of the Company in accordance with the Articles of

Association and the Listing Rules.

 

7. THAT, the directors of the Company be and are hereby generally and unconditionally authorised in accordance with section 551 of the Companies Act 2006 (the "Act"), to exercise all of the powers of the Company to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company ("Rights") up to an aggregate nominal value of £400,000, representing approximately 272% of the issued share capital of the Company as at 1 April 2022, being the latest practical date prior to publication of this document, provided that the authority conferred by this Resolution 7 shall expire at the conclusion of the Company's next annual general meeting or on the expiry of fifteen months following the passing of this Resolution 7, whichever is the later (unless previously renewed, varied or revoked by the Company in general meeting).

 

Special Resolutions

 

8. That, the Directors be and hereby are empowered pursuant to Section 570(1) of CA 2006 to allot or make offers or agreements to allot equity securities (which expression shall have the meaning ascribed to it in Section 560(1) of CA 2006) for cash pursuant to the authority given in accordance with Section 551 of CA 2006 by Resolution 7 above as if Section 561(1) of CA 2006 did not apply to such allotments, provided that the power provided by this Resolution 8 shall expire at the conclusion of the Company's next annual general meeting or on the expiry of fifteen months following the passing of this Resolution 8, whichever is the later (unless previously renewed, varied or revoked by the Company in general meeting).

 

9. That, the Company be and is hereby authorised to make one or more market purchases (within the meaning of section 693(4) of the CA 2006) of Ordinary Shares provided that:

 

9.1 the maximum aggregate number of Ordinary Shares authorised to be purchased is an

amount equal to 14.99% of the issued Ordinary Shares;

 

9.2 the minimum price which may be paid for an Ordinary Share is their nominal value;

 

9.3 the maximum price which may be paid for an Ordinary Share is an amount equal to the

higher of (i) 105% of the average of the middle market quotation per Share taken from

the London Stock Exchange daily official list for the five Business Days immediately

preceding the day on which such Ordinary Share is to be purchased; and (ii) the amount

stipulated by the UK version of Article 5(6) of Market Abuse Regulation

(596/2014/EU); and

 

9.4 unless renewed, the authority hereby conferred shall expire either at the conclusion of

the annual general meeting of the Company following the passing of this Resolution 9

or on the expiry of fifteen months from the passing of this Resolution 9, whichever is

the later, save that the Company may, prior to such expiry, enter into a contract to

purchase Ordinary Shares which will or may be completed or executed wholly or partly

after such expiry.

 

 

 

 

Resolution

For & Discretionary

Against

Withheld

1.

Directors' Report and Financial Statements and Auditor's Report

 

22,616

 

0

 

0

2.

Directors' Remuneration Report

22,616

0

0

3.

Re-appoint BDO LLP as auditor

22,616

0

0

4.

Auditor remuneration

22,616

0

0

5.

Re-elect Kate Jones

22,616

0

0

6.

Re-elect Reuben Wilcock

22,616

0

0

7.

Allot shares

22,616

0

0

8.

Authority to disapply pre-emption rights

22,616

0

0

9.

Share buyback authority

22,616

0

0

 

 

For further information please contact:

 

Blackfinch Investments Limited (Investment Manager) - 01452 717070

 

The City Partnership (UK) Limited (Company Secretary) - enquiries@city.uk.com - Robin Smeaton

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSSIFSAEESELM
Date   Source Headline
4th Jun 20263:51 pmRNSResults of AGM, 4 June 2026
21st May 20265:36 pmRNSDividend Declaration
18th May 20261:05 pmRNSIssue of Equity
7th May 20267:00 amRNSIssue of a Supplementary Prospectus
6th May 20269:46 amRNSTotal Voting Rights
28th Apr 20269:50 amRNSNet Asset Value per Share
21st Apr 20267:00 amRNSAnnual Financial Report
14th Apr 202612:59 pmRNSAdmission of Further Securities to Trading
31st Mar 20269:45 amRNSUtilisation of Over-allotment Facility
26th Mar 20261:48 pmRNSIssue of Equity
27th Feb 20267:00 amRNSIssue of Equity
2nd Feb 20265:17 pmRNSNet Asset Value per Ordinary Share
30th Jan 20264:59 pmRNSAdmission of Further Securities to Trading
28th Jan 20263:58 pmRNSIssue of Equity
27th Jan 20263:44 pmRNSChange of Registered Office Address
26th Jan 20262:23 pmRNSDeclaration of Interim Dividend
17th Dec 20256:26 pmRNSIssue of Equity
17th Dec 20256:22 pmRNSPurchase of Own Shares
20th Nov 20254:30 pmRNSIssue of Equity
19th Nov 20256:28 pmRNSIssue of Equity
10th Nov 20257:00 amRNSNet Asset Value per Share
19th Sep 20256:12 pmRNSPurchase of Own Shares
11th Sep 202511:49 amRNSPublication of Prospectus
26th Aug 20257:00 amRNSIssue of Equity
19th Aug 20254:26 pmRNSHalf-year Report
8th Aug 20255:01 pmRNSIssue of Equity
1st Aug 20259:07 amRNSNet Asset Value per Share
25th Jun 202512:37 pmRNSIssue of Equity
5th Jun 20256:12 pmRNSResult of AGM
2nd Jun 20253:55 pmRNSPurchase of own Securities
23rd May 202511:10 amRNSDeclaration of Interim Dividend
9th May 20254:25 pmRNSIssue of Equity
8th May 20251:39 pmRNSIssue of a Supplementary.Prospectus
6th May 20255:22 pmRNSNet Asset Value per Share
25th Apr 20256:28 pmRNSAnnual Financial Report
4th Apr 20253:06 pmRNSIssue of Equity
2nd Apr 20255:13 pmRNSIssue of Equity
31st Mar 202512:38 pmRNSUtilisation of Over-allotment Facility
26th Mar 20254:25 pmRNSIssue of Equity
27th Feb 20251:34 pmRNSIssue of Equity
11th Feb 20253:56 pmRNSNet Asset Value(s)
29th Jan 20255:52 pmRNSIssue of Equity
20th Jan 20255:21 pmRNSDividend Declaration
2nd Jan 20253:58 pmRNSTotal Voting Rights
13th Dec 20243:35 pmRNSIssue of Equity
4th Dec 20249:58 amRNSTotal Voting Rights
15th Nov 20245:11 pmRNSIssue of Equity
30th Oct 202411:59 amRNSIssue of Equity
28th Oct 202412:09 pmRNSNet Asset Value per Share as at 30 September 2024
10th Oct 20242:33 pmRNSResults of a General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.